SEC Form 4/A · accession 0000899243-18-029696
Fuse Medical, Inc. · FZMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Christopher C Reeg
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Aug 1, 2018
Accepted (ET)
Nov 27, 2018 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000319016
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F4 | Aug 1, 2018 | P | 2,539,474 | $0.76 | A | 6,539,474 | I | By Reeg Medical Industries, Inc. |
| Common StockF3,F4 | Oct 4, 2018 | P | 72,139 | $0.68 | A | 6,611,613 | I | By Reeg Medical Industries, Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4/A amends the Form 4 filed by Christopher C. Reeg ("Reeg") on August 3, 2018, to correct the number of shares of common stock, par value $0.01 (the "Common Stock"), of the Fuse Medical, Inc., a Delaware corporation (the "Company"), that Reeg received pursuant to that certain Securities Purchase Agreement, dated July 30, 2018 (the "Maxim Purchase Agreement"), by and between the Company, Palm Springs Partners, LLC d/b/a Maxim Surgical, a Texas limited liability company ("Maxim"), Reeg Medical Industries, Inc., a Texas corporation ("RMI"), Mr. Amir David Tahernia, an individual ("Tahernia", together with RMI, the "Sellers"), and Tahernia in his capacity as the representative of the Sellers (the "Sellers Representative").
- F2(Continued from Footnote 1) The Company made a calculation error when computing the number of shares of Common Stock issued to RMI, and corrected the number in its Current Report on Form 8-K/A filed with the Securities and Exchange Commission (the "SEC") on November 16, 2018 (the "Maxim Form 8-K/A").
- F3On October 4, 2018, the Company issued 72,139 shares of Common Stock to RMI, which represents RMI's pro rata share of the agreed-upon purchase price adjustment pursuant to Pursuant to the Maxim Purchase Agreement, as reported in the Maxim Form 8-K/A.
- F4These securities are directly owned by RMI. Reeg is the sole shareholder, sole director, and sole officer of RMI. Accordingly, Reeg indirectly beneficially owns the reported securities.